The decreased NPTX2 in CSF in our data suggests that the adaptative control of the pyramidal neuron-fast-spiking parvalbumin circuit could be damaged in the ALS patient’s brain. This evidence concerns the gene PVALB and amyotrophic lateral sclerosis.